Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Nov;119(6):1248–1254. doi: 10.1111/j.1476-5381.1996.tb16029.x

Rilmenidine and reflex renal sympathetic nerve activation in Wistar and hypertensive rats.

T Zhang 1, E J Johns 1
PMCID: PMC1915907  PMID: 8937730

Abstract

1. This study sets out to examine the effect of rilmenidine administered systemically on basal and reflexly activated renal nerve activity in Wistar and stroke prone spontaneously hypertensive rats (SHRSP). 2. Animals were anaesthetized with chloralose/urethane, stimulating electrodes were placed on the brachial plexi and the renal nerves were isolated and put on recording electrodes. Both brachial nerves were stimulated electrically at 0.8, 1.6 and 3.2 Hz (15 V, 0.2 ms) in the absence and in the presence of rilmenidine given at 100 and 200 micrograms kg-1 i.v. in a cumulative manner. 3. Stimulation of the brachial nerves caused graded increases in blood pressure, heart rate and integrated renal nerve activity (P < 0.05) in both Wistar and SHRSP. Fast Fourier transformation of the renal nerve activity signal to generate a power spectrum demonstrated that both total power and percentage power at heart rate was higher in the SHRSP than Wistar (P < 0.05). Total power was raised during brachial nerve stimulation in both Wistar and SHRSP by some 200-300% (P < 0.05) but the percentage power at heart rate was decreased by some 60% (P < 0.01) in the Wistar but was raised by some 40-50% (P < 0.05) in the SHRSP. 4. Administration of rilmenidine caused dose-related decreases in blood pressure and heart rate and integrated renal nerve activity in both Wistar and SHRSP (all P < 0.05). Both doses of rilmenidine decreased (P < 0.05) the total power in the signal in both strains of rat by about one-half but the power occurring at heart rate only fell at the higher dose of compound in the Wistar, whereas in the SHRSP it was decreased by both doses by approximately 60-70%. In the presence of rilmenidine, coherence of the renal nerve signal was reduced in the Wistar and SHRSP and although the drug had no effect on phase difference in the Wistar, this parameter was decreased in the SHRSP by the low and high doses of rilmenidine (P < 0.05). 5. In the presence of 100 micrograms kg-1 rilmenidine, stimulation of the brachial nerves caused increases in total power in the Wistar and SHRSP (two to three fold, P < 0.05), together with a decrease (P < 0.05) in the percentage power occurring at heart rate in the Wistar, of some 60%, and an increase (P < 0.01) in the SHRSP, of some two to three times, which were very similar in magnitude and pattern to those obtained in the absence of the drug. Following the 200 micrograms kg-1 dose of rilmenidine, brachial nerve stimulation increased total power in the Wistar and SHRSP groups (P < 0.05) and whereas in the Wistar the percentage power at heart rate did not change in the SHRSP it was again increased in response to the electrical stimulation of the brachial plexus (P < 0.001) by between two to three fold. 6. These results showed that in both the Wistar and SHRSP rilmenidine depressed blood pressure, heart rate and integrated renal nerve activity. Moreover, rilmenidine did not affect the reflex activation of renal nerve activity via the somatosensory system although the characteristics within the power spectra underwent certain changes which might have a functional impact at the level to the kidney.

Full text

PDF
1248

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davis G., Johns E. J. Baroreceptor and somatic sensory regulation of kidney function in two-kidney, one-clip Goldblatt hypertensive rats. J Physiol. 1994 Apr 1;476(1):167–176. [PMC free article] [PubMed] [Google Scholar]
  2. Davis G., Johns E. J. Renal sympathetic nerve responses to somato-sensory nerve stimulation in normotensive rats. J Auton Nerv Syst. 1995 Jul 14;54(1):59–70. doi: 10.1016/0165-1838(94)00190-u. [DOI] [PubMed] [Google Scholar]
  3. Davis G., Johns E. J. Somatosensory regulation of renal function in the stroke-prone spontaneously hypertensive rat. J Physiol. 1994 Dec 15;481(Pt 3):753–759. doi: 10.1113/jphysiol.1994.sp020479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DiBona G. F., Sawin L. L. Reflex regulation of renal nerve activity in cardiac failure. Am J Physiol. 1994 Jan;266(1 Pt 2):R27–R39. doi: 10.1152/ajpregu.1994.266.1.R27. [DOI] [PubMed] [Google Scholar]
  5. DiBona G. F., Sawin L. L. Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. Am J Physiol. 1991 Feb;260(2 Pt 2):R298–R305. doi: 10.1152/ajpregu.1991.260.2.R298. [DOI] [PubMed] [Google Scholar]
  6. Dubar M., Pillion G. I1 agents: a new approach to the treatment of hypertension. Ann N Y Acad Sci. 1995 Jul 12;763:642–658. doi: 10.1111/j.1749-6632.1995.tb32459.x. [DOI] [PubMed] [Google Scholar]
  7. Ernsberger P., Giuliano R., Willette R. N., Reis D. J. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther. 1990 Apr;253(1):408–418. [PubMed] [Google Scholar]
  8. Gargalidis-Moudanos C., Parini A. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells. J Cardiovasc Pharmacol. 1995;26 (Suppl 2):S59–S62. [PubMed] [Google Scholar]
  9. Head G. A., Godwin S. J., Sannajust F. Differential receptors involved in the cardiovascular effects of clonidine and rilmenidine in conscious rabbits. J Hypertens Suppl. 1993 Dec;11(5):S322–S323. [PubMed] [Google Scholar]
  10. Johns E. J., Manitius J. An investigation into the neural regulation of calcium excretion by the rat kidney. J Physiol. 1987 Feb;383:745–755. doi: 10.1113/jphysiol.1987.sp016439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kline R. L., Cechetto D. F. Renal effects of rilmenidine in anesthetized rats: importance of renal nerves. J Pharmacol Exp Ther. 1993 Sep;266(3):1556–1562. [PubMed] [Google Scholar]
  12. Li P., Penner S. B., Smyth D. D. Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats. Br J Pharmacol. 1994 May;112(1):200–206. doi: 10.1111/j.1476-5381.1994.tb13052.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Osborn J. L., Johns E. J. Renal neurogenic control of renin and prostaglandin release. Miner Electrolyte Metab. 1989;15(1-2):51–58. [PubMed] [Google Scholar]
  14. Panfilov V. V., Reid J. L. Brain and autonomic mechanisms in hypertension. J Hypertens. 1994 Apr;12(4):337–343. [PubMed] [Google Scholar]
  15. Rouse D., Williams S., Suki W. N. Clonidine inhibits fluid absorption in the rabbit proximal convoluted renal tubule. Kidney Int. 1990 Jul;38(1):80–85. doi: 10.1038/ki.1990.170. [DOI] [PubMed] [Google Scholar]
  16. Sannajust F., Barrès C., Koenig-Bérard E., Sassard J. Sympathoinhibitory effects of rilmenidine may be mediated by sites located below the brainstem. Br J Pharmacol. 1992 Mar;105(3):535–541. doi: 10.1111/j.1476-5381.1992.tb09015.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sannajust F., Head G. A. Effect of rilmenidine on baroreflex control of renal sympathetic nerve activity. J Hypertens Suppl. 1993 Dec;11(5):S328–S329. [PubMed] [Google Scholar]
  18. Szabo B., Urban R., Starke K. Sympathoinhibition by rilmenidine in conscious rabbits: involvement of alpha 2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):593–600. doi: 10.1007/BF00167235. [DOI] [PubMed] [Google Scholar]
  19. Urban R., Szabo B., Starke K. Involvement of alpha 2-adrenoceptors in the cardiovascular effects of moxonidine. Eur J Pharmacol. 1995 Aug 25;282(1-3):19–28. doi: 10.1016/0014-2999(95)00297-x. [DOI] [PubMed] [Google Scholar]
  20. Urban R., Szabo B., Starke K. Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304. Eur J Pharmacol. 1995 Aug 25;282(1-3):29–37. doi: 10.1016/0014-2999(95)00265-m. [DOI] [PubMed] [Google Scholar]
  21. Wyss J. M., Oparil S., Sripairojthikoon W. Neuronal control of the kidney: contribution to hypertension. Can J Physiol Pharmacol. 1992 May;70(5):759–770. doi: 10.1139/y92-100. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES